An Electrochemical Study of Antineoplastic Gallium, Iron and Ruthenium Complexes with Redox Noninnocent α-N-Heterocyclic Chalcogensemicarbazones
- 30 October 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 47 (23) , 11032-11047
Abstract
The electrochemical properties of a series of α-N-heterocyclic chalcogensemicarbazones (HL), namely, thiosemicarbazones, selenosemicarbazones, and semicarbazones, and their gallium(III), iron(III), and ruthenium(III) complexes with the general formula [ML2][Y] (M = Ga, Fe or Ru; Y = PF6−, NO3−, or FeCl4−) were studied by cyclic voltammetry. The novel compounds were characterized by elemental analysis, a number of spectroscopic methods (NMR, UV−vis, IR), mass spectrometry and by X-ray crystallography. All complexes show several, mostly reversible, redox waves attributable to the reduction of the noninnocent chalcogensemicarbazone ligands at lower potentials (<−0.4 V vs NHE) than the metal-centered iron or ruthenium redox waves (>0 V vs NHE) in organic electrolyte solutions. The cyclic voltammograms of the gallium complexes display at least two consecutive reversible one-electron reduction waves. These reductions are shifted by ∼0.6 V to lower potentials in the corresponding iron and ruthenium complexes. The electrochemical, chemical, and spectroscopic data indicate that the ligand-centered reduction takes place at the CH3C═N double bond. Quantum chemical calculations on the geometric and electronic structures of 2-acetylpyridine 4N,4N-dimethylthiosemicarbazone (HLB), the corresponding metal complexes [Ga(LB)2]+ and [FeII(LB)2], and the one-electron reduction product for each of these species support the assignment of the reduction site and elucidate the observed order of the ligand-centered redox potentials, E1/2([FeII(L)2]) < E1/2(HL) < E1/2([Ga(L)2]+). The influence of water on the redox potentials of the complexes is reported and the physiological relevance of the electrochemical data for cytotoxicity as well as for ribonucleotide reductase inhibitory capacity are discussed.Keywords
This publication has 66 references indexed in Scilit:
- In Vitro and In Vivo Evaluation of Bifunctional Bisthiosemicarbazone 64Cu-Complexes for the Positron Emission Tomography Imaging of HypoxiaJournal of Medicinal Chemistry, 2008
- π•−π• Bonding Interactions Generated by Halogen Oxidation of Zirconium(IV) Redox-Active Ligand ComplexesJournal of the American Chemical Society, 2008
- Synthesis, Characterization, and Properties of Some Copper(II) Complexes of 2‐Pyridineformamide Thiosemicarbazone (HAm4DH)European Journal of Inorganic Chemistry, 2006
- Redox-Active Antineoplastic Ruthenium Complexes with Indazole: Correlation of in Vitro Potency and Reduction PotentialJournal of Medicinal Chemistry, 2005
- The mechanism of action of platinum(IV) complexes in ovarian cancer cell linesJournal of Inorganic Biochemistry, 2004
- Tuning of Redox Potentials for the Design of Ruthenium Anticancer Drugs − an Electrochemical Study of [trans-RuCl4L(DMSO)]- and [trans-RuCl4L2]- Complexes, where L = Imidazole, 1,2,4-Triazole, IndazoleInorganic Chemistry, 2004
- Pyridazines 47. The Configuration of Novel Thiosemicarboazone Derivatives of Pyridazinecarbaldehydes and Alkyl Pyridazinyl KetonesHETEROCYCLES, 1989
- Ab initio effective core potentials for molecular calculations. Potentials for K to Au including the outermost core orbitalsThe Journal of Chemical Physics, 1985
- Electronic substituent effects upon properties of 5-substituted-2-formylpyridine thiosemicarbazones and their metal complexesJournal of Inorganic Biochemistry, 1979
- Study of Steric Effects by Electron Spin Resonance Spectroscopy and Polarography. Substituted Nitrobenzenes and NitroanilinesJournal of the American Chemical Society, 1964